Longevity Health Holdings, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

XAGE$0.130.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Deficit

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’** EQUITY (DEFICIT)**

Three and Six Months Ended June 30, 2026 and 2025

· · Common Stock · · · Additional Paid-in · · · Accumulated · · · · ·
· · Shares · · · Amount · · · Capital · · · Deficit · · · Total ·
Balance at March 31, 2026	2,475,321	$247	$70,313,494	$(77,208,657)	$(6,894,916)
Stock-based compensation expense	—	—	78,759	—	78,759
Net loss	—	—	—	(1,883,290)	(1,883,290)
Balance at June 30, 2026	2,475,321	$247	$70,392,253	$(79,091,947)	$(8,699,447)


Balance at March 31, 2025	1,004,117	$100	$66,572,144	$(70,377,529)	$(3,805,285)
Common Stock issued, net of costs	479,621	48	1,759,818	—	1,759,866
Stock-based compensation expense	—	—	194,323	—	194,323
Net loss	—	—	—	(1,886,438)	(1,886,438)
Balance at June 30, 2025	1,483,738	$148	$68,526,285	$(72,263,967)	$(3,737,534)


Balance at January 1, 2026	1,781,738	$178	$69,909,893	$(75,776,944)	$(5,866,873)
Common Stock issued, net of costs	689,656	69	189,932	—	190,001
Common Stock issued for Elevai Acquisition	3,927	—	67,742	—	67,742
Stock-based compensation expense	—	—	224,686	—	224,686
Net loss	—	—	—	(3,315,003)	(3,315,003)
Balance at June 30, 2026	2,475,321	$247	$70,392,253	$(79,091,947)	$(8,699,447)


Balance at January 1, 2025	696,969	$70	$64,158,930	$(68,871,662)	$(4,712,662)
Common Stock issued, net of costs	748,461	74	3,397,402	—	3,397,476
Common Stock issued for Elevai Acquisition	38,308	4	660,801	—	660,805
Stock-based compensation expense	—	—	309,152	—	309,152
Net loss	—	—	—	(3,392,305)	(3,392,305)
Balance at June 30, 2025	1,483,738	$148	$68,526,285	$(72,263,967)	$(3,737,534)

-5-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.